Characterization of the immunoprotective antigen of ribosomal preparations from Haemophilus influenzae.
This investigation was designed to characterize the immunoprotective antigen of ribosomal preparations from Haemophilus influenzae. The ribosomes that elicited 80 to 90% protection contained 25% protein and 75% ribonucleic acid but did not contain any detectable hexoses. The immunodiffusion and hemagglutination inhibition tests also failed to demonstrate that the capsular material (polyribose phosphate) was in ribosomal preparations. Treatment of ribosomes with ribonuclease degraded 78% ribonucleic acid but did not affect the immunogenicity of such preparations. The proteolytic enzymes reduced the immunogenicity of ribosomes corresponding to the amount of protein degraded. The protection elicited by ribosomal protein extracted with 2-chloroethanol was comparable to that induced by intact ribosomes. In contrast, the low levels of protection observed by immunization with phenol-extracted ribonucleic acid were dependent on the amounts of contaminating protein. Finally, immunogenicity of ribosomal ribonucleic acid and protein was abrogated by treatment with proteolytic enzymes. These results clearly indicate that the protein associated with Haemophilus ribosomes is the major immunoprotective antigen.
D000818:Animals; D000942:Antigens, Bacterial; D001426:Bacterial Proteins / Q000276:immunology; D001428:Bacterial Vaccines; D006192:Haemophilus Infections / Q000517:prevention & control*; D006193:Haemophilus influenzae / Q000276:immunology*; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D012329:RNA, Bacterial / Q000276:immunology; D012335:RNA, Ribosomal / Q000276:immunology; D011817:Rabbits; D012269:Ribosomal Proteins / Q000276:immunology; D012270:Ribosomes / Q000276:immunology; D013696:Temperature
D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D001428:Bacterial Vaccines; D012329:RNA, Bacterial; D012335:RNA, Ribosomal; D012269:Ribosomal Proteins